Table 2 Comparison of clinical findings of patients with EPE and n-EPE
From: Incidence, aetiology and clinical features of eosinophilic pleural effusion: a retrospective study
Total (n = 252) | EPE (n = 34) | n-EPE (n = 218) | p-Value | |
|---|---|---|---|---|
Age (y) | 58 (19–98) | 56.4 (25–88) | 58.2 (19–98) | 0.56 |
Sex | 0.48 | |||
Male | 162 (64.3%) | 20 (58.8%) | 142 (65.1%) | |
Female | 90 (35.7%) | 14 (41.2%) | 76 (34.9%) | |
Peripheral blood | ||||
WBC (× 109/L) | 8.2 (3.0–42.4) | 8.6 (3.2–21.4) | 9.3 (3.0–42.4) | 0.42 |
LYM (× 109/L) | 1.4 (0.2–13.5) | 1.3 (0.3–2.5) | 1.3 (0.2–13.5) | 0.93 |
EO (× 106/L) | 253.7 (0–6200.0) | 514.7 (0–5778.0) | 168.3 (0–6200.0) | 0.001 |
Pleural effusion | ||||
LDH (U/L) | 943 (25- 44,144) | 369 (90–1402) | 1098 (25- 44,144.0) | 0.30 |
GLU (mmol/L) | 5.80 (0.12–50.21) | 6.07 (3.02–9.77) | 5.70 (0.12–50.21) | 0.64 |
Protein (g/L) | 77.1 (5.2–182.9) | 48.03 (27.5–182.9) | 47.8 (5.2–57.3) | 0.66 |
ADA (U/L) | 19.5 (0.1–196.7) | 10.4 (0.1- 44.7) | 22.4 (0.1–196.7) | 0.007 |
CEA (ng/mL) | 715.60 (0.2–69,984.0) | 106.39 (0.30–2087.0) | 770.80 (0.2–69,984.0) | 0.74 |
WBC (× 109/L) | 1.5 (0–12.9) | 3.2 (0.1–12.9) | 1.2 (0–8.6) | 0.001 |
EO (%) | 5.0 (0–67.5) | 21.7 (10.0–67.5) | 1.3 (0–8.0) | < 0.01 |
RBC (× 109/L) | 44.6 (0.08–990,000) | 111.2 (0.2–2986.7) | 30,607.0 (0.7–990,000) | 0.36 |